# FDA recall D-1322-2020

> **Glaxosmithkline Consumer Healthcare Holdings** · Class II · drug recall initiated 2020-05-28.

## Product

Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42

## Reason for recall

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-1322-2020
- **Recalling firm:** Glaxosmithkline Consumer Healthcare Holdings
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-28
- **Report date:** 2020-06-24
- **Termination date:** 2022-01-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Warren, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1322-2020

## Citation

> AI Analytics. FDA recall D-1322-2020. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1322-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*